2 options
Ketek clinical study fraud : what did Aventis know? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, February 12, 2008.
Connect to full text Available online
View online- Format:
- Book
- Government document
- Author/Creator:
- United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
- Language:
- English
- Subjects (All):
- Telithromycin--Testing--Corrupt practices--United States.
- Telithromycin.
- Antibiotics--Testing--Corrupt practices--United States.
- Antibiotics.
- Clinical trials--Corrupt practices--United States.
- Clinical trials.
- Drug approval--United States.
- Drug approval.
- United States.
- Physical Description:
- 1 online resource (iii, 187 pages)
- Place of Publication:
- Washington : U.S. G.P.O., 2008.
- Notes:
- Title from title screen (viewed on June 15, 2009).
- Paper version available for sale by the Supt. of Docs., U.S.G.P.O.
- Includes bibliographical references.
- "Serial no. 110-87."
- Other Format:
- United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. Ketek clinical study fraud
- OCLC:
- 399633050
- Access Restriction:
- Use copy Restrictions unspecified
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.